Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 trial assessing safety, tolerability, PK and PD of GLPG1690 in idiopathic pulmonary fibrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: OASIS-IPF (Idiopathic Pulmonary Fibrosis) Study
Clinical trial update for the OASIS-IPF study in idiopathic pulmonary fibrosis; study completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF [Phase 2]
Phase 2 trial evaluating safety and tolerability of GBT440 in IPF patients has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension [Phase 2]
Phase 2 trial update on treprostinil for patients with pulmonary arterial hypertension associated with interstitial lung disease, including …
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 trial assessing safety and efficacy of pamrevlumab (FG-3019) in idiopathic pulmonary fibrosis has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest [Phase 2]
Phase 2 study evaluating GBT440 in subjects with idiopathic pulmonary fibrosis on supplemental oxygen was terminated; results posted in 2020…
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: Morphine for Dyspnea in Pulmonary Fibrosis [Phase 3]
Phase 3 clinical trial update evaluating morphine for dyspnea in idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial update on SAR156597 for idiopathic pulmonary fibrosis reports efficacy and safety data post-completion.
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 clinical trial of STX-100 in idiopathic pulmonary fibrosis (IPF) has completed and results were posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Inhaled NO in IPF and COPD During 6 Minute Walk Test [Phase 2]
Phase 2 trial exploring inhaled nitric oxide effects in COPD and idiopathic pulmonary fibrosis during the six-minute walk test.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial evaluating safety, tolerability, and efficacy in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis
Observational study of IPF (FIBRONET) completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-12Clinical Trial Update: Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging [Phase 1]
Phase 1 trial update for single doses of GSK3008348 in idiopathic pulmonary fibrosis with PET imaging; study terminated with results posted …
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment [Phase 4]
Phase 4 trial evaluating nintedanib effects on extracellular matrix turnover biomarkers in idiopathic pulmonary fibrosis with limited forced…
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain
A completed real-world chart review study describing the clinical profile of idiopathic pulmonary fibrosis patients treated with nintedanib …
-
CLINICAL_TRIALS trial_result · 2019-07-15Clinical Trial Update: Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial update investigating the effect of Fostair on biomarkers of platelet adhesion in idiopathic pulmonary fibrosis (IPF).
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 rollover study update for BIBF 1120 in idiopathic pulmonary fibrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-22Clinical Trial Update: Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial assessing a lysophosphatidic acid receptor antagonist for idiopathic pulmonary fibrosis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 study evaluating safety and tolerability of PBI-4050 in patients with idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-03-04Clinical Trial Update: A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination [Phase 4]
A phase 4 trial comparing blood levels of nintedanib and pirfenidone when given separately or in combination for idiopathic pulmonary fibros…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Cromolyn Detection of Silent Aspiration [Phase 1]
A Phase 1 study evaluating cromolyn for detecting silent aspiration was terminated; it addressed conditions including gastroesophageal reflu…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis [NA]
Completed clinical trial evaluating home-based pulmonary rehabilitation for idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects [Phase 1]
A Phase 1 trial evaluating tolerability, pharmacokinetics, and the food effect of ZL-2102 in healthy male subjects.
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis [NA]
A completed clinical trial evaluating patient-reported symptom monitoring and spirometry via the patientMpower platform in idiopathic pulmon…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis [Phase 3]
Phase 3 clinical trial of ART-123 for acute exacerbation of idiopathic pulmonary fibrosis has completed, according to the trial registry upd…